Tyler J Loftus1, Alicia M Mohr, Lyle L Moldawer. 1. Department of Surgery, Sepsis and Critical Illness Research Center, University of Florida Health, University of Florida College of Medicine, Gainesville, Florida, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to describe recent findings in the context of previous work regarding dysregulated myelopoiesis and hematopoietic function following an acute physiologic insult, focusing on the expansion and persistence of myeloid-deriver suppressor cells, the deterioration of lymphocyte number and function, and the inadequacy of stress erythropoiesis. RECENT FINDINGS: Persistent myeloid-derived suppressor cell (MDSC) expansion among critically ill septic patients is associated with T-cell suppression, vulnerability to nosocomial infection, chronic critical illness, and poor long-term functional status. Multiple approaches targeting MDSC expansion and suppressor cell activity may serve as a primary or adjunctive therapeutic intervention. Traumatic injury and the neuroendocrine stress response suppress bone marrow erythropoietin receptor expression in a process that may be reversed by nonselective beta-adrenergic receptor blockade. Hepcidin-mediated iron-restricted anemia of critical illness requires further investigation of novel approaches involving erythropoiesis-stimulating agents, iron administration, and hepcidin modulation. SUMMARY: Emergency myelopoiesis is a dynamic process with unique phenotypes for different physiologic insults and host factors. Following an acute physiologic insult, critically ill patients are subject to persistent MDSC expansion, deterioration of lymphocyte number and function, and inadequate stress erythropoiesis. Better strategies are required to identify patients who are most likely to benefit from targeted therapies.
PURPOSE OF REVIEW: The purpose of this review is to describe recent findings in the context of previous work regarding dysregulated myelopoiesis and hematopoietic function following an acute physiologic insult, focusing on the expansion and persistence of myeloid-deriver suppressor cells, the deterioration of lymphocyte number and function, and the inadequacy of stress erythropoiesis. RECENT FINDINGS: Persistent myeloid-derived suppressor cell (MDSC) expansion among critically ill septicpatients is associated with T-cell suppression, vulnerability to nosocomial infection, chronic critical illness, and poor long-term functional status. Multiple approaches targeting MDSC expansion and suppressor cell activity may serve as a primary or adjunctive therapeutic intervention. Traumatic injury and the neuroendocrine stress response suppress bone marrow erythropoietin receptor expression in a process that may be reversed by nonselective beta-adrenergic receptor blockade. Hepcidin-mediated iron-restricted anemia of critical illness requires further investigation of novel approaches involving erythropoiesis-stimulating agents, iron administration, and hepcidin modulation. SUMMARY: Emergency myelopoiesis is a dynamic process with unique phenotypes for different physiologic insults and host factors. Following an acute physiologic insult, critically illpatients are subject to persistent MDSC expansion, deterioration of lymphocyte number and function, and inadequate stress erythropoiesis. Better strategies are required to identify patients who are most likely to benefit from targeted therapies.
Authors: Whitney A Young; Eleanor A Fallon; Daithi S Heffernan; Philip A Efron; William G Cioffi; Alfred Ayala Journal: Surgery Date: 2016-12-21 Impact factor: 3.982
Authors: Junko Ozao-Choy; Ge Ma; Johnny Kao; George X Wang; Marcia Meseck; Max Sung; Myron Schwartz; Celia M Divino; Ping-Ying Pan; Shu-Hsia Chen Journal: Cancer Res Date: 2009-03-10 Impact factor: 12.701
Authors: Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer Journal: J Exp Med Date: 2007-06-04 Impact factor: 14.307
Authors: Anita K McElroy; Rama S Akondy; David R Mcllwain; Han Chen; Zach Bjornson-Hooper; Nilanjan Mukherjee; Aneesh K Mehta; Garry Nolan; Stuart T Nichol; Christina F Spiropoulou Journal: JCI Insight Date: 2020-05-21
Authors: Jennifer M Leonard; Christina X Zhang; Liang Lu; Mark H Hoofnagle; Anja Fuchs; Regina A Clemens; Sarbani Ghosh; Shin-Wen Hughes; Grant V Bochicchio; Richard Hotchkiss; Isaiah R Turnbull Journal: J Trauma Acute Care Surg Date: 2021-06-01 Impact factor: 3.697
Authors: Isaiah R Turnbull; Anja Fuchs; Kenneth E Remy; Michael P Kelly; Elfaridah P Frazier; Sarbani Ghosh; Shin-Wen Chang; Monty B Mazer; Annie Hess; Jennifer M Leonard; Mark H Hoofnagle; Marco Colonna; Richard S Hotchkiss Journal: PLoS One Date: 2022-04-14 Impact factor: 3.240
Authors: Aaron J Wilk; Madeline J Lee; Bei Wei; Benjamin Parks; Ruoxi Pi; Giovanny J Martínez-Colón; Thanmayi Ranganath; Nancy Q Zhao; Shalina Taylor; Winston Becker; David Jimenez-Morales; Andra L Blomkalns; Ruth O'Hara; Euan A Ashley; Kari C Nadeau; Samuel Yang; Susan Holmes; Marlene Rabinovitch; Angela J Rogers; William J Greenleaf; Catherine A Blish Journal: J Exp Med Date: 2021-06-15 Impact factor: 17.579
Authors: Chunhua Fu; Yuanqing Lu; Mason A Williams; Mark L Brantly; Corey E Ventetuolo; Laurence M Morel; Borna Mehrad; Edward W Scott; Andrew J Bryant Journal: Br J Pharmacol Date: 2020-02-04 Impact factor: 9.473
Authors: Viktor Fleming; Xiaoying Hu; Rebekka Weber; Vasyl Nagibin; Christopher Groth; Peter Altevogt; Jochen Utikal; Viktor Umansky Journal: Front Immunol Date: 2018-03-02 Impact factor: 7.561
Authors: Jonas Schulte-Schrepping; Nico Reusch; Daniela Paclik; Kevin Baßler; Stephan Schlickeiser; Bowen Zhang; Benjamin Krämer; Tobias Krammer; Sophia Brumhard; Lorenzo Bonaguro; Elena De Domenico; Daniel Wendisch; Martin Grasshoff; Theodore S Kapellos; Michael Beckstette; Tal Pecht; Adem Saglam; Oliver Dietrich; Henrik E Mei; Axel R Schulz; Claudia Conrad; Désirée Kunkel; Ehsan Vafadarnejad; Cheng-Jian Xu; Arik Horne; Miriam Herbert; Anna Drews; Charlotte Thibeault; Moritz Pfeiffer; Stefan Hippenstiel; Andreas Hocke; Holger Müller-Redetzky; Katrin-Moira Heim; Felix Machleidt; Alexander Uhrig; Laure Bosquillon de Jarcy; Linda Jürgens; Miriam Stegemann; Christoph R Glösenkamp; Hans-Dieter Volk; Christine Goffinet; Markus Landthaler; Emanuel Wyler; Philipp Georg; Maria Schneider; Chantip Dang-Heine; Nick Neuwinger; Kai Kappert; Rudolf Tauber; Victor Corman; Jan Raabe; Kim Melanie Kaiser; Michael To Vinh; Gereon Rieke; Christian Meisel; Thomas Ulas; Matthias Becker; Robert Geffers; Martin Witzenrath; Christian Drosten; Norbert Suttorp; Christof von Kalle; Florian Kurth; Kristian Händler; Joachim L Schultze; Anna C Aschenbrenner; Yang Li; Jacob Nattermann; Birgit Sawitzki; Antoine-Emmanuel Saliba; Leif Erik Sander Journal: Cell Date: 2020-08-05 Impact factor: 41.582
Authors: Lillian Hesselink; Okan W Bastian; Marjolein Heeres; Maarten Ten Berg; Albert Huisman; Imo E Hoefer; Wouter W van Solinge; Leo Koenderman; Karlijn J P van Wessem; Luke P H Leenen; Falco Hietbrink Journal: Acta Orthop Date: 2018-08-06 Impact factor: 3.717